Greenleaf Peter - Insider Non-Derivative Transactions at Aurinia Pharmaceuticals Inc. (AUPH) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Mar 6, 2024, Greenleaf Peter's relationship to Aurinia Pharmaceuticals Inc. (AUPH) is Director,Officer (Chief Executive Officer), and currently has 1,522,114 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other AUPH insiders.
Data Source: SEC.
Greenleaf Peter - Insider Non-Derivative Transactions of AUPH Common Stock
Greenleaf Peter - Insider Non-Derivative Transactions at AUPH
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Mar 7, 2024 | Sell -- (Common Stock) | 126981 | 5.6 | 1522114 |
| Feb 21, 2024 | Acquisition -- (Common Stock) | 661538 | 0 | 1649095 |
| Mar 3, 2023 | Sell -- (Common Stock) | 33047 | 8.78 | 982671 |
| Mar 3, 2023 | Sell -- (Common Stock) | 32750 | 8.94 | 982968 |
| Mar 3, 2023 | Acquisition -- (Common Stock) | 667407 | 0 | 1015718 |